American Beacon ARK Transformational Innovation Fd;R6
Limited financial coverage for ADNRX.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The Fund seeks long-term growth of capital. The Fund seeks to achieve its objective by investing primarily all of the Fund's assets in domestic and foreign equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to disruptive innovation.
- IPO
- 2020
- HQ
- Albany, NY, US
Get TickerSpark's AI analysis on ADNRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $26.35
- 52W Low
- $17.56
- 50D MA
- $23.85
- 200D MA
- $21.75
- Beta
- 2.43
- RSI (14)
- 48
- Avg Volume
- 0
No earnings-call transcripts are available for ADNRX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 7.44M
- Float Shares
- 0
Our ADNRX coverage
Recent articles, reports, and earnings notes.
No research on ADNRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ADNRX report →